Search Results 581-590 of 16041 for pharmacogenetics

  1. APDA Center for Advanced Research - Neuroscience - Mayo Clinic Research

    The APDA Center for Advanced Research at Mayo Clinic conducts research to find new treatments for Parkinson's disease, Lewy body dementia and related ...

  2. Prospective Research Rare Kidney Stones - Mayo Clinic

    The purpose of this study is to determine the natural history of the hereditary forms of nephrolithiasis and chronic kidney disease (CKD), primary hyperoxaluria ...

  3. Study of Sparsentan in Patients with Primary Focal Segmental Glomerulosclerosis - Mayo Clinic

    The purpose of this study is to determine the long-term nephroprotective potential of treatment with sparsentan as compared to an angiotensin receptor blocker ...

  4. Solitary Bone Plasmacytomas to Elucidate Their Pathogenesis and Risk of Progression to Multiple Myeloma - Mayo Clinic

    About this study. The purpose of this study is to obtain archived residual formalin-fixed-paraffin-embedded tissue from diagnostic biopsies of solitary bone ...

  5. A Phase 1/2 Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Glanzmann Thrombasthenia - Mayo Clinic

    The purpose of this study is to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Participants with Glanzmann ...

  6. Leukemia Clinical Trials

    Drugs used in chemotherapy, such as cytarabine, daunorubicin hydrochloride, idarubicin, and vorinostat, work in different ways to stop the growth of cancer ...

  7. Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer - Mayo Clinic

    Blocking PARP may help keep tumor cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy. Adding ...

  8. Mutational Analysis of Alternative Pathway Complement Regulatory Proteins - Mayo Clinic

    The purpose of this study is to develop and validate full gene-sequencing assays or known mutation sequencing assays for the evaluation of patients with ...

  9. CRISPR/Cas9 Targeting - Transgenic and Knockout Core - Mayo Clinic Research

    The Transgenic and Knockout Core can develop mice with targeted mutations such as deletions, small insertions or point mutations directly in fertilized embryos.

  10. Next-generation sequencing for colorectal cancer detects germline predisposition for 1 in 6 patients - Mayo Clinic

    A prospective, multisite study found 1 in 6 patients with colorectal cancer had a germline predisposition and more than half of those would not have been ...